INDEX PHARMACEUTICALS
InDex Pharmaceuticals AB is a clinical stage biopharmaceutical company building a leading immunotherapy franchise based on its TLR platform (toll-like receptors). It discovers and develops DIMS drugs (DNA-based immunomodulatory sequence) to treat diseases within a variety of therapeutic areas, including inflammation and cancer.
INDEX PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical
Founded:
2000-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.indexpharma.com
Total Employee:
11+
Status:
Active
Contact:
46 8 50 88 47 30
Total Funding:
31.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Board_member
2020-04-01
Board_member
2016-01-01
Board_member
Board_member
Board_member
Board_member
2011-02-01
Current Employees Featured
Christine Dieterich Johansson Senior Project Manager CMC and Pre-clinical @ InDex Pharmaceuticals
Senior Project Manager CMC and Pre-clinical
Johan Gileus Chief Financial Officer @ InDex Pharmaceuticals
Chief Financial Officer
Thomas Knittel Chief Medical Officer @ InDex Pharmaceuticals
Chief Medical Officer
2012-01-01
Per-Olof Gunnesson VP Finance&Business Development @ InDex Pharmaceuticals
VP Finance&Business Development
2002-06-01
Peter Zerhouni Chief Executive Officer @ InDex Pharmaceuticals
Chief Executive Officer
Founder
Investors List
Vinnova
Vinnova investment in Grant - InDex Pharmaceuticals
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - InDex Pharmaceuticals
Vinnova
Vinnova investment in Grant - InDex Pharmaceuticals
Industrifonden
Industrifonden investment in Venture Round - InDex Pharmaceuticals
Neomed Management
Neomed Management investment in Venture Round - InDex Pharmaceuticals
SEB Venture Capital
SEB Venture Capital investment in Venture Round - InDex Pharmaceuticals
SEB Venture Capital
SEB Venture Capital investment in Private Equity Round - InDex Pharmaceuticals
Industrifonden
Industrifonden investment in Private Equity Round - InDex Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.indexpharma.com Semrush global rank: 6.08 M Semrush visits lastest month: 1.34 K
- Host name: 172.67.142.191
- IP address: 172.67.142.191
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "InDex Pharmaceuticals"
InDex Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email info@indexpharma.com Phone Number 46 8 50 88 47 30 InDex Pharmaceuticals AB is a clinical stage biopharmaceutical company building a leading immunotherapy franchise …See details»
InDex Pharmaceuticals AB - LinkedIn
Indexpharma.com 59 Like Comment Share InDex Pharmaceuticals AB 1,480 followers 8mo Report this post Today, InDex Pharmaceuticals Holding AB published the Annual Report for …See details»
InDex Pharmaceuticals strengthens the organization with Eva
May 2, 2022 – InDex Pharmaceuticals Holding AB (publ) today announced that the company has appointed Eva Arlander as Chief Development Officer. Eva will also be part of the …See details»
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report …
Request to info@indexpharma.com, or by mail to InDex Pharmaceuticals Holding AB (publ), Berzelius väg 13, 171 65 Solna, Sweden. For more information: Jenny Sundqvist, CEO …See details»
InDex Pharmaceuticals strengthens the clinical development …
Aug 23, 2021 E-mail: peter.zerhouni@indexpharma.com. Publication The information was submitted for publication through the agency of the contact person set out above at 08:00 CET …See details»
About Us – Index Pharmaceuticals
Founded in 1998 by the forward-thinking Mr. Amish Shah, Index Pharma LLP emerged from his seven-year immersion in the pharmaceutical industry, where he cultivated relationships and …See details»
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report …
Send request to info@indexpharma.com, or by mail to InDex Pharmaceuticals Holding AB (publ), Tomtebodavägen 23a, 171 77 Stockholm. For more information: Peter Zerhouni, CEO Phone: …See details»
Index Pharmaceuticals
Index Pharma has facilitated more than 15 audits for our customers and suppliers. Our 3rd party audits foster trust, support customers and suppliers, facilitating seamless business in India.See details»
InDex Pharmaceuticals - Overview, News & Similar companies
Notice of extraordinary general meeting in InDex Pharmaceuticals Holding AB (publ) May 6, 2024 - The shareholders of InDex Pharmaceuticals Holding AB, reg.no. 559067-6820 (the …See details»
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report …
E-mail: peter.zerhouni@indexpharma.com Publication The information was submitted for publication through the agency of the contact person set out above at 08:00 CET on April 23, …See details»
Inex Pharmaceuticals strengthens the organization with va …
E-mail: johan.gileus@indexpharma.com Publication The information was submitted for publication through the agency of the contact person set out above at 11:45 CET on May 2, 2022. InDex …See details»
InDex Pharmaceuticals - PharmaBoardroom
Oct 18, 2019 Peter Zerhouni – CEO, InDex Pharmaceuticals, Sweden. InDex Pharmaceuticals is a Swedish biopharma company developing drugs that could help patients suffering from …See details»
InDex Pharmaceuticals Holding AB (publ) publishes Annual ... - Flerie
Apr 8, 2024 Send request to info@indexpharma.com, or by mail to InDex Pharmaceuticals Holding AB (publ), Berzelius väg 13, 171 65 Solna, Sweden. For more information: Jenny …See details»
InDex Pharmaceuticals has entered into a conditional ... - Placera
May 20, 2024 E-mail: johan.gileus@indexpharma.com. Ted Fjällman, CEO of Flerie E-mail: contact@flerie.com. This information is information that InDex Pharmaceuticals Holding AB …See details»
InDex Pharmaceuticals - Company Profile - Tracxn
Nov 29, 2024 InDex Pharmaceuticals develops drugs for the treatment of ulcerative colitis. It offers Kappaproct, a DNA-based immunomodulatory sequence medication (TLR Agonists) that …See details»
InDex Pharmaceuticals - Craft
Aug 13, 2024 InDex Pharmaceuticals has 5 employees at their 1 location and kr97.51 m in annual revenue in FY 2023. See insights on InDex Pharmaceuticals including office locations, …See details»
InDex Pharmaceuticals Holding AB (publ) publishes Annual ... - Flerie
Apr 8, 2022 The Annual Report is mailed to shareholders and other stakeholders who specifically request it. Send request to info@indexpharma.com, or by mail to InDex …See details»
InDex Pharmaceuticals strengthens the organization with Eva …
May 2, 2022 InDex is based in Stockholm, Sweden. The company’s shares (ticker INDEX) are traded on Nasdaq First North Growth Market Stockholm. Redeye AB with email address …See details»
Biopharma Trends: Focus on Innovation Amid Complexity | BCG
3 days ago BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures. We work in a uniquely collaborative model …See details»
InDex Pharmaceuticals provides an update on company’s future
Feb 26, 2024 E-mail: jenny.sundqvist@indexpharma.com. Johan Giléus, CFO and deputy CEO Phone: +46 8 122 038 50 E-mail: johan.gileus@indexpharma.com. Publication The …See details»